Global Hepatitis Diagnostic Test Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Hepatitis Diagnostic Test Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Test Type (Blood Tests (Liver Function Tests, Immunoassays, and Nucleic Acid Tests), Imaging Test, and Liver Biopsy), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Hepatitis Diagnostic Test Market was valued at USD 4,424.03 million in 2023 and is expected to reach USD 6,945.49 million by 2031 while growing at a CAGR of 5.8% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global hepatitis diagnostic test market growth. Hepatitis diagnostic tests are employed to detect and diagnose inflammation of the liver, known as hepatitis. This condition is primarily caused by viral infections, but other factors such as alcohol abuse, autoimmune diseases, and certain medications can also contribute. The tests aim to pinpoint the underlying cause of hepatitis, evaluate the extent of liver damage, and direct suitable treatment and management plans.
The rising prevalence of hepatitis, coupled with technological advancements like rapid diagnostic tests and nucleic acid testing (NAT), propels the hepatitis diagnostic test market forward. Nonetheless, high costs and societal stigma could hinder market growth.
Furthermore, the global hepatitis diagnostic test industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Test Type Analysis
The Global Hepatitis Diagnostic Test Market is segmented among Blood Tests, Imaging Test, and Liver Biopsy, based on Test Type. In 2023, Blood Tests accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Hepatitis Diagnostic Test Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Abbott Laboratories, Danaher Corporation (Beckman Coulter Inc), BioMerieux SA, Bio-Rad Laboratories Inc, Diasorin S.p.A, F. Hoffmann-La Roche AG, Hologic Inc, VWR International, LLC, Qaigen Inc, and Grifols SA.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Hepatitis Diagnostic Test Market Dynamics
Drivers
Restraints
Opportunity
4. Global Hepatitis Diagnostic Test Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Hepatitis Diagnostic Test Market Segmentation, By Test Type
Global Hepatitis Diagnostic Test Market Share Analysis, By Test Type
Global Hepatitis Diagnostic Test Market Growth Analysis, By Test Type
Global Hepatitis Diagnostic Test Market Trends, By Test Type
o Blood Tests
Ø Liver Function Tests
Ø Immunoassays
Ø Nucleic Acid Tests
o Imaging Test
o Liver Biopsy
6. Global Hepatitis Diagnostic Test Market Segmentation, By Region
Global Hepatitis Diagnostic Test Market Share Analysis, By Region
Global Hepatitis Diagnostic Test Market Growth Analysis, By Region
Global Hepatitis Diagnostic Test Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
7. Competitive Landscape
Abbott Laboratories*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Danaher Corporation (Beckman Coulter Inc)
BioMerieux SA
Bio-Rad Laboratories Inc
Diasorin S.p.A
F. Hoffmann-La Roche AG
Hologic Inc
VWR International, LLC
Qaigen Inc
Grifols SA
*Similar analysis will be provided for each company listed above.